By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


Company News
AstraZeneca PLC (AZN) Will Invest $200M, Add 300 Jobs In Maryland Plant Expansion 11/21/2014 9:28:33 AM
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca PLC (AZN) At European Cancer Symposium 11/21/2014 9:26:05 AM
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014 5:49:55 AM
AstraZeneca PLC (AZN) Presents Data From Phase 3 Studies Of Lesinurad In Combination With Allopurinol In Gout Patients At American College of Rheumatology 2014 Annual Meeting 11/17/2014 12:56:11 PM
Deal-Hungry Pfizer (PFE) Unlikely To Make Fresh Bid For AstraZeneca PLC (AZN) 11/14/2014 6:54:28 AM
AstraZeneca PLC (AZN) And Isis Pharmaceuticals, Inc. (ISIS) To Co-Develop Targeted Oligonucleotide Delivery Methods 11/13/2014 8:40:28 AM
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent 11/13/2014 6:09:31 AM
Amgen (AMGN) And AstraZeneca PLC (AZN) Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 11/12/2014 6:08:18 AM
Amgen (AMGN) And AstraZeneca PLC (AZN)'s Psoriasis Drug Tops Johnson & Johnson (JNJ)'s Stelara In Phase 3 Study 11/12/2014 6:07:17 AM
AstraZeneca PLC (AZN) To Present New Data From Its Growing Inflammation And Autoimmunity Pipeline At American College of Rheumatology 2014 Annual Meeting 11/11/2014 12:11:26 PM